Literature DB >> 1897257

New technologies in newborn screening.

E W Naylor.   

Abstract

Mesh：

Year:  1991        PMID： 1897257      PMCID： PMC2589456     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


× No keyword cloud information.
  11 in total

1.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

2.  Duchenne muscular dystrophy: neonatal screening and prenatal diagnosis.

Authors:  H Plauchu; C Dorche; M P Cordier; P Guibaud; J M Robert
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

3.  Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening.

Authors:  J E Dankert-Roelse; G J te Meerman; A Martijn; L P ten Kate; K Knol
Journal:  J Pediatr       Date:  1989-03       Impact factor: 4.406

4.  Neonatal screening for cystic fibrosis.

Authors:  G Mastella; E G Barlocco
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

5.  Dried-blood spot screening for cystic fibrosis in the newborn.

Authors:  J R Crossley; R B Elliott; P A Smith
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

6.  Muscular dystrophy screening.

Authors:  L M Drummond; A M Veale
Journal:  Lancet       Date:  1978-06-10       Impact factor: 79.321

7.  Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.

Authors:  E Bonilla; C E Samitt; A F Miranda; A P Hays; G Salviati; S DiMauro; L M Kunkel; E P Hoffman; L P Rowland
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

8.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.

Authors:  G Scheuerbrandt; A Lundin; T Lövgren; W Mortier
Journal:  Muscle Nerve       Date:  1986-01       Impact factor: 3.217

10.  Improved diagnosis of Becker muscular dystrophy by dystrophin testing.

Authors:  E P Hoffman; L M Kunkel; C Angelini; A Clarke; M Johnson; J B Harris
Journal:  Neurology       Date:  1989-08       Impact factor: 9.910
View more
  2 in total

1.  Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).

Authors:  Stuart J Moat; Donald M Bradley; Rachel Salmon; Angus Clarke; Louise Hartley
Journal:  Eur J Hum Genet       Date:  2013-01-23       Impact factor: 4.246

2.  Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing.

Authors:  Shuai Han; Hong Xu; Jinxian Zheng; Junhui Sun; Xue Feng; Yue Wang; Wen Ye; Qing Ke; Yanwei Ren; Shulie Yao; Songying Zhang; Jianfen Chen; Robert C Griggs; Zhengyan Zhao; Ming Qi; Michele A Gatheridge
Journal:  Biomed Res Int       Date:  2020-09-27       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.